Phase II trial of vorinostat in advanced melanoma.
Haas NB, Quirt I, Hotte S, McWhirter E, Polintan R, Litwin S, Adams PD, McBryan T, Wang L, Martin LP, vonMehren M, Alpaugh RK, Zweibel J, Oza A.
Haas NB, et al. Among authors: litwin s.
Invest New Drugs. 2014 Jun;32(3):526-34. doi: 10.1007/s10637-014-0066-9. Epub 2014 Jan 25.
Invest New Drugs. 2014.
PMID: 24464266
Clinical Trial.